Search research articles
Contact Us
Filters
Showing results (31-40 of 36) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 36 results.
Health Affairs (Project Hope)
|
May 11, 2006
Malpractice premiums and physicians' income: perceptions of a crisis conflict with empirical evidence
Marc A Rodwin, Hak J Chang, Jeffrey Clausen
Ethics & Behavior
|
January 1, 1993
Case vignette: inside information
Frederick R Kobrick, Marc A Rodwin, Gary R VandenBos
Health Affairs (Project Hope)
|
May 14, 2008
Malpractice premiums in Massachusetts, a high-risk state: 1975 to 2005
Marc A Rodwin, Hak J Chang, Melissa M Ozaeta, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 7, 2021
The use of 'added benefit' to determine the price of new anti-cancer drugs in France, 2004-2017
Marc A Rodwin, Julien Mancini, Ségolène Duran, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 17, 2021
Corrigendum to "The use of 'added benefit' to determine the price of new anti-cancer drugs in France, 2004-2017" [Eur J Canc 145 (2021) 11-18]
Marc A Rodwin, Julien Mancini, Ségolène Duran, et al.
BMJ (Clinical Research Ed.)
|
December 5, 2019
Pathways to independence: towards producing and using trustworthy evidence
Ray Moynihan, Lisa Bero, Sue Hill, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 36) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 36 results.
Health Affairs (Project Hope)
|
May 11, 2006
Malpractice premiums and physicians' income: perceptions of a crisis conflict with empirical evidence
Marc A Rodwin, Hak J Chang, Jeffrey Clausen
Ethics & Behavior
|
January 1, 1993
Case vignette: inside information
Frederick R Kobrick, Marc A Rodwin, Gary R VandenBos
Health Affairs (Project Hope)
|
May 14, 2008
Malpractice premiums in Massachusetts, a high-risk state: 1975 to 2005
Marc A Rodwin, Hak J Chang, Melissa M Ozaeta, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 7, 2021
The use of 'added benefit' to determine the price of new anti-cancer drugs in France, 2004-2017
Marc A Rodwin, Julien Mancini, Ségolène Duran, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 17, 2021
Corrigendum to "The use of 'added benefit' to determine the price of new anti-cancer drugs in France, 2004-2017" [Eur J Canc 145 (2021) 11-18]
Marc A Rodwin, Julien Mancini, Ségolène Duran, et al.
BMJ (Clinical Research Ed.)
|
December 5, 2019
Pathways to independence: towards producing and using trustworthy evidence
Ray Moynihan, Lisa Bero, Sue Hill, et al.
Page
of 4